Industrials
Strata Critical Medical, Inc.(SRTA)
Live Price
Offline$5.88
+1.55% today
1Y Change
+54.40%
Window
Jun 20, 2025 โ Jun 5, 2026
- Market Cap
- $440.00M
- Revenue Growth
- -20.7%
- EPS Growth
- +242.9%
- Dividend Yield
- 0.0%
Coverage: 241 bars ยท Jun 20, 2025 โ Jun 5, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Strata Critical Medical, Inc. (SRTA) is a Industrials stock with a market cap of $440.00M and listed on NASDAQ. The stock last traded around $5.88 and up 54.4% across the available one-year price window (Jun 20, 2025 โ Jun 5, 2026). Baseline metrics include revenue growth of -20.7%, EPS growth of +242.9%, a dividend yield of 0.0%. What stands out right now is revenue -20.7%, EPS +242.9%, free cash flow -64.8% with operating margin -11.3% and ROIC 15.8%. Valuation is more restrained than many high-expectation growth names at P/E 10.1 and price/sales 2.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SRTA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-20.7% vs +3.6% peer median
Operating Margin
Below sector median
-11.3% vs +16.9% peer median
P/E
Below sector median
10.1 vs 36.7 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 11, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -20.7% and EPS is at +242.9%, with operating margin around -11.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -5.5% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 11, 2026 | โ | -3.4% | -5.1% | โ |
2026 Mar 3, 2026 | -721.4% | +1.9% | -3.1% | -12.9% |
2025 Nov 10, 2025 | -200.0% | +3.9% | -8.2% | -6.4% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SRTA
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SRTA Max Drawdown
-32.21%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SRTA and SPY.
Company Overview
Strata Critical Medical, Inc.
NASDAQ Global Market
Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
- Leadership
- Melissa Tomkiel
- IPO Date
- Nov 5, 2019
- Employees
- 310
- Street Address
- 31 Hudson Yards
- Mailing
- New York, NY, 10001
- Region
- New York, NY, US
- Reporting Currency
- USD
- Investor Line
- 212 967 1009
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 10.1
- EV/EBITDA
- โ
- Price/Sales
- 2.2
- Price/Book
- 1.5
Growth
- Revenue
- -20.7%
- EPS
- +242.9%
- Free Cash Flow
- -64.8%
Profitability
- Gross Margin
- 20.9%
- Operating Margin
- -11.3%
- Net Margin
- 21.0%
- ROE
- 16.5%
- ROIC
- 15.8%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 6.38
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.